News

March 22, 2018

HealthPRO Launches Pandemic Staff Supply Contract for Oseltamivir Phosphate (Tamiflu®)

HealthPRO recently launched a pandemic supply contract for Oseltamivir Phosphate 75 mg capsules, commonly known by its brand name, Tamiflu®.

Driven by the need of several Ontario-based HealthPRO members, this contract is specifically for pandemic stockpile supply to be used for antiviral prophylaxis for hospital staff, physicians, and volunteers in the event of an influenza pandemic.

This contract was awarded to both Hoffman-La Roche (Tamiflu®) and Natco Pharma (Nat-oseltamivir), providing members the ability to select the product that best suits their institutional requirements.

To ensure best value, members who wish to join the contract are required to commit in advance to purchasing a predetermined quantity as a one-time purchase for their respective facility’s pandemic stockpile.

The contract commenced February 15th, 2018 and is open to all members for commitment.

For more information, please contact:

Sara Saral
Business Director, Pharmacy Innovation
ssaral@healthprocanada.com